Oral care labeling
This article was originally published in The Rose Sheet
Executive Summary
FDA exempts OTC dentifrices, mouthwash and mouth rinse products that contain sodium, calcium, magnesium or potassium from final rule requiring cautionary labeling for products intended for oral ingestion, agency states in the March 24 Federal Register in one 1notice for sodium and another 2notice for the remaining ingredients. FDA says it concurs with industry, which argued in comments that oral products do not pose the same risks as those ingested orally because the amount absorbed or accidentally ingested would be too small to pose a health threat. Industry also maintained that cautionary labeling could falsely suggest the products are intended for oral ingestion. FDA had proposed including the product categories in an amendment to a proposed final rule in1996. Final rule is effective April 23...
You may also be interested in...
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
BMS Has A Strong Pipeline, But Access Challenges Remain
Bristol Myers Squibb’s head of major markets, Monica Shaw, wants to improve patients’ access to lifesaving therapies. And the group has several new products ready to roll.
Novartis Hires Ex-BMS Chief As It Pursues US Growth Strategy
The Swiss pharma company is looking to tap into the experience of ex-BMS leader Giovanni Caforio to help further it US-first commercial strategy.